Today is the final day to bid for the Emcure Pharmaceuticals IPO, and it has received strong interest from investors. By the second day, the IPO was ...

Emcure Pharmaceuticals' initial public offering (IPO) has garnered strong investor interest, with subscriptions reaching 4.98 times the offered shares on the ...

The Emcure Pharmaceuticals IPO, starting tomorrow, 3rd July 2024, is set to bring in around ₹127.87 crore for Namita Thapar, a popular investor from Shark ...